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that there may be a useful quantitative relationship
between short-term mutagenicity data and long-
term carcinogenicity data. Not surprisingly, they
conclude that such a relationship is unlikely (at
least that is how I interpreted their guarded
conclusions).
There is an excellent chapter by Carrano and
Moore on methods for quantifying sister-chromatid
exchange in humans. The authors supply some
valuable data which demonstrates the variability of
SCE levels in human peripheral lymphocytes and
emphasise the need for rigorous statistical design of
protocols.
Despite its uneven coverage, this volume will be a
very useful source of reference to anyone interested
in genetic toxicology, and does succeed in
demonstrating the versatility of short-term tests in
allowing investigations which would have been
impossible only one or two decades ago.
S. Venitt,
Institute for Cancer Research,
Pollards Wood Research Station,
Chalfont St. Giles, Bucks.
Prostaglandins and Cancer. (Prostaglandins and
Related Lipids-Vol. 2). (Eds. T. J. POWLES, R. S.
BOCKMAN, K. V. HONN and P. RAMWELL) New
York, Alan R. Liss Inc., 841 pp, 1982.
This book records the proceedings of the "First
International Conference on Prostaglandins and
Cancer" held in 1981 with the stated objective of
bringing together those scientists involved in
prostaglandin research, with those involved in
cancer research. These proceedings indicate that
this objective was fulfilled, although the bias is
towards the biology rather than the chemistry of
the prostaglandins.
It is divided into eight major sections. The first
comprises four review articles which provide an
excellent introduction to the metabolism and
pharmacology of the prostaglandins. The remaining
sections are each divided into review papers and
brief reports. Many of the latter are so insubstantial
as to only add to the bulk of an overlong book
without adding significantly to its value.
The second and third sections cover respectively,
the initiation and promotion phases of
carcinogenesis. The former provides in-depth
reviews on the role of prostaglandin oxygenases in
the synthesis of carcinogenic metabolites, whilst the
latter is concerned with the actual role that the
prostaglandins may play in tumour promotion.
The next two sections concern the role of
prostaglandins in the control of cell replica-
tion/proliferation and cell differentiation/inter-
action. These are followed by a section entitled
Prostaglandins, bone metastases and hypercalcaemia
which closely relates to the following section
covering host-tumour interactions. These two
sections attempt to integrate the relationship and
relative roles of prostaglandins synthesised by the
tumour cell and the host during tumour
progression.
The concluding section, covering the effect of
pharmacological manipulation of prostaglandin
synthesis on tumour growth and metastasis in vivo,
describes potential applications to the treatment of
cancer. The final paper in this section describes the
sole human study and concludes on the depressing
note that the infusion of prostaglandins known to
inhibit tumour cell proliferation in experimental
systems has no effect on the progression of human
cancer. This disappointing result is in contrast to
the work described elsewhere in this book, which
covers an exciting interaction between two areas of
scientific research.
Specialists in the field of prostaglandin research
will probably gain little from this book, but those
oncologists prepared to delve into its 841 pages will
find many papers of interest.
K. Moore,
CRC Medical Oncology Unit,
Southampton General Hospital,
Southampton
Pharmacologic Principles of Cancer Treatment. (Ed.
B. CHABNER) USA, W. B. Saunders Company, 457
pp, 1982, £45.00
Over the last five years there have been a number
of books dealing with the pharmacology of anti-
cancer drugs. Although these have been of interest
there has really been no authoritative volume that
has dealt with this subject in depth. This is the first
time I have had the opportunity to review such a
text and I feel that this will fill a real need for all
those concerned in oncology. The book is divided
into two sections, the first contains excellent
reviews on the principles of cell kinetics,
pharmacokinetics, clinical pharmacology and late
complications of drug therapy. The second section
is devoted to individual chapters on all the
commonly used cytotoxic agents. Each is
comprehensively covered and an authoritative
bibliography appended. Throughout,. the text
presents a unanimity that holds the reader's
attention, diagrams and tables are clearly labelled,
and not overdone. This book should appeal to all
those involved in the care of the patient with